First trimester prediction of HELLP syndrome

被引:18
作者
Oliveira, Natacha [1 ]
Poon, Liona C. [2 ]
Nicolaides, Kypros H. [2 ]
Baschat, Ahmet A. [1 ]
机构
[1] Johns Hopkins Sch Med, Gynecol & Obstet, Baltimore, MD USA
[2] Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, London, England
关键词
ELEVATED LIVER-ENZYMES; UTERINE ARTERY DOPPLER; HYPERTENSIVE DISORDERS; PAPP-A; PREECLAMPSIA; PREGNANCY; HEMOLYSIS; PRESSURE;
D O I
10.1002/pd.4694
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objective The aim of this study was to evaluate first-trimester maternal characteristics and biomarkers in pregnancies that subsequently develop HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Method Maternal history, biochemical, and biophysical parameters were compared between women who developed HELLP, preeclampsia (PE) without HELLP and controls. After determination of significant variables through univariate analysis a first-trimester prediction model was obtained by applying logistic regression analysis. Performance of the model was evaluated. Results Twenty participants with HELLP were compared with 147 patients that developed PE without HELLP and 2810 controls. Women with HELLP were more likely Caucasian, nulliparous and presented a higher mean arterial pressure (MAP) when compared with controls. As opposing to women who developed HELLP, women who developed PE without HELLP were more likely of African-American origin and presented an even higher first-trimester MAP. Enrollment biochemical and biophysical parameters were similar between HELLP and PE or controls. Ethnicity, nulliparity, history of previous PE, history of previous HELLP syndrome, and first-trimester MAP were primary risk factors. A prediction rule for HELLP syndrome had an area under the curve of 0.80, with 75% sensitivity for 79% specificity. Conclusion The majority of pregnancies that develop HELLP syndrome can be predicted in the first trimester. (C) 2015 John Wiley & Sons, Ltd.
引用
收藏
页码:29 / 33
页数:5
相关论文
共 21 条
[1]   Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review [J].
Abildgaard, Ulrich ;
Heimdal, Ketil .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 166 (02) :117-123
[2]   The HELLP syndrome, a prospective study [J].
Abraham, KA ;
Connolly, G ;
Farrell, J ;
Walshe, JJ .
RENAL FAILURE, 2001, 23 (05) :705-713
[3]  
ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67
[4]   Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks [J].
Akolekar, Ranjit ;
Syngelaki, Argyro ;
Sarquis, Rita ;
Zvanca, Mona ;
Nicolaides, Kypros H. .
PRENATAL DIAGNOSIS, 2011, 31 (01) :66-74
[5]   PAPP-A levels of late pregnancy in preeclampsia and HELLP syndrome [J].
Atis, Alev ;
Aydin, Yavuz ;
Basol, Elif ;
Kaleli, Semih ;
Turgay, Fatma ;
Goker, Nimet .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 285 (01) :45-49
[6]   Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome [J].
Audibert, F ;
Friedman, SA ;
Frangieh, AY ;
Sibai, BM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 175 (02) :460-464
[7]   First-trimester screening for pre-eclampsia: moving from personalized risk prediction to prevention [J].
Baschat, A. A. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2015, 45 (02) :119-129
[8]   Prediction of preeclampsia utilizing the first trimester screening examination [J].
Baschat, Ahmet A. ;
Magder, Laurence S. ;
Doyle, Lauren E. ;
Atlas, Robert O. ;
Jenkins, Chuka B. ;
Blitzer, Miriam G. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 211 (05) :514.e1-514.e7
[9]   Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy A Meta-Analysis [J].
Bujold, Emmanuel ;
Roberge, Stephanie ;
Lacasse, Yves ;
Bureau, Marc ;
Audibert, Francois ;
Marcoux, Sylvie ;
Forest, Jean-Claude ;
Giguere, Yves .
OBSTETRICS AND GYNECOLOGY, 2010, 116 (02) :402-414
[10]   Risk Factors, Management, and Outcomes of Hemolysis, Elevated Liver Enzymes, and Low Platelets Syndrome and Elevated Liver Enzymes, Low Platelets Syndrome [J].
Fitzpatrick, Kathryn E. ;
Hinshaw, Kim ;
Kurinczuk, Jennifer J. ;
Knight, Marian .
OBSTETRICS AND GYNECOLOGY, 2014, 123 (03) :618-627